The Food and Drug Administration is adding a warning about rare vision loss to popular GLP-1 drugs, the widely prescribed medications used for diabetes and weight loss. The Associated Press reports the label change reflects newly reviewed safety data tied to the drug class. Patients taking these medications should be aware of the potential risk and talk with their doctors about any changes in their eyesight.